NCT02689531View on ClinicalTrials.gov

CTTI Risk Factors for HABP/VABP Study

CompletedOBSERVATIONAL

Enrollment

7,530

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions

Pneumonia, Ventilator-AssociatedPneumonia, BacterialPneumonia, Hospital-Acquired

Trial Locations (15)

Unknown

Birmingham

Los Angeles

Chicago

Louisville

New Orleans

Detroit

Royal Oak

St Louis

Rochester

Durham

Cleveland

Philadelphia

Pittsburgh

Charleston

Nashville

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

Clinical Trials Transformation Initiative

OTHER

collaborator

Food and Drug Administration (FDA)

FED

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Duke University

OTHER

NCT02689531 - CTTI Risk Factors for HABP/VABP Study | Biotech Hunter | Biotech Hunter